Literature DB >> 24269432

[Papillitis due to Epstein-Barr virus infection in an adult patient].

E Santos-Bueso1, F Sáenz-Francés2, C Méndez-Hernández2, J M Martínez-de-la-Casa2, J García-Feijoo2, J A Gegúndez-Fernández2, J García-Sánchez2.   

Abstract

CASE REPORT: A 70-year- old woman who consulted due to poor vision in her right eye for 2 weeks. The examination showed a visual acuity (VA) of 0.6 and 1.0, with normal anterior pole and intraocular pressure and a relative afferent pupillary defect. Some papillitis was observed in the fundus of her right eye. The high levels of acute phase reactants led to an initial diagnosis of arteritic anterior ischemic optic neuropathy (AAION) and treatment with corticosteroids was started. DISCUSSION: According to the age of the patient, the fundus and the high levels of acute phase reactants, the initial diagnosis was AAION. However, the atypical papillitis features, with good AV and non-specific perimetry, together with a suitable medical history, and a profile of viral characteristics, with laboratory confirmation, led to the diagnosis of a primary papillitis infection due to Epstein-Barr virus, a very rare case due to the advanced age of the patient.
Copyright © 2013 Sociedad Española de Oftalmología. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Epstein Barr; Neuritis; Papilitis; Papillitis; Primary infection; Primoinfección; Virus

Mesh:

Substances:

Year:  2013        PMID: 24269432     DOI: 10.1016/j.oftal.2013.05.007

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  2 in total

1.  Epstein-Barr Virus Neuroretinitis in a Lung Transplant Patient.

Authors:  Yen C Hsia; Peter V Chin-Hong; Marc H Levin
Journal:  J Neuroophthalmol       Date:  2017-03       Impact factor: 3.042

Review 2.  Infectious optic neuropathies: a clinical update.

Authors:  Rim Kahloun; Nesrine Abroug; Imen Ksiaa; Anis Mahmoud; Hatem Zeghidi; Sonia Zaouali; Moncef Khairallah
Journal:  Eye Brain       Date:  2015-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.